Patent ID: 7875726

Claim:
A pharmaceutical composition containing at least one thiazolidin-4-one derivative of the Formula (I) wherein: R 1 represents lower alkenyl; cycloalkyl; 5,6,7,8-tetrahydronaphth-1-yl; 5,6,7,8-tetrahydronaphth-2-yl; a phenyl group; or a phenyl group independently mono-, di- or tri-substituted with lower alkyl, halogen, lower alkoxy, or —CF 3 ; R 2 represents lower alkyl; allyl; cyclopropyl; cyclobutyl; cyclopentyl; or mono- or di-lower alkylamino; R 3 represents —NR 5 R 6 ; R 4 represents hydrogen; hydroxy; lower alkoxy; lower alkyl; or halogen; or R 3 and R 4 together may form a methylenedioxy or ethylenedioxy ring optionally further substituted with a hydroxy-methyl group; and R 5 and R 6 each represents independently lower alkyl; or configurational isomers, optically pure enantiomers, mixtures of enantiomers, enantiomeric racemates, diastereomers, mixtures of diastereomers, diastereomeric racemates, or mixtures of diastereomeric racemates, in free or pharmaceutically acceptable salt form, and an inert carrier material.